The burgeoning field of wearable health technology, once primarily focused on fitness tracking, is rapidly evolving to offer deeper insights into our metabolic health. A recent discussion at CES 2026, moderated by The Spoon and featuring a diverse panel of experts, illuminated the profound potential of continuous glucose monitoring (CGM) and other advanced biosensors to revolutionize dietary habits and, consequently, public health outcomes. The conversation underscored that while the technology itself is a powerful tool, its true value lies in its ability to translate raw data into actionable insights and sustained behavioral change.
The Personal Revelation of Continuous Glucose Monitoring
The impetus for this exploration stemmed from a personal revelation. After a trial period with an over-the-counter (OTC) continuous glucose monitor (CGM), the author experienced a profound shift in understanding how diet impacts the body. The immediate feedback provided by the device demonstrated how specific food choices, particularly those high in sugar, caused dramatic spikes in blood glucose levels. Conversely, the data revealed the stabilizing effect of nutrient-rich foods like salads and vegetables, and the significant role of even light physical activity, such as a post-meal walk, in mitigating these spikes. This firsthand experience ignited a crucial question: could widespread access to such technology empower millions to better manage their health, transforming societal dietary patterns over time?
CES 2026: A Forum for Future Health Insights
This very question formed the core of "From Brainwaves to Blood Sugar: How Next-Gen Tech Shapes Diets," a pivotal session held during The Spoon’s Food Tech Conference at CES 2026 in Las Vegas. The Consumer Electronics Show, a global stage for innovation, provided an ideal backdrop for discussing cutting-edge advancements. The session’s deliberate inclusion of a multidisciplinary panel—comprising a physician, startup founders, an investor, and a researcher—was designed to foster a comprehensive dialogue on the multifaceted implications of these emerging technologies.
The Power of Data: From Limited Readings to Richer Understanding
Dr. Howard Zisser, a veteran in diabetes technology and a pioneer in early CGM systems, emphasized the transformative impact of OTC CGMs. Historically, CGM technology was largely confined to individuals diagnosed with diabetes, requiring a prescription and often involving a more clinical context. However, the advent of accessible, over-the-counter devices, like the Stelo CGM mentioned in the author’s experience, democratizes this powerful diagnostic tool.
"Instead of one or two readings a day, you suddenly have 300, 500, 600 readings a day," Dr. Zisser explained. This exponential increase in data points allows users to observe intricate trends and patterns that were previously invisible. These include glucose fluctuations during fasting periods, the impact of exercise, and even the influence of hormonal cycles like menstruation. "You get a rich data set that’s your data personally," he added, highlighting the highly individualized nature of the insights gained.
Dr. Zisser further elaborated on the psychological impact of immediate glucose feedback. He posited that the initial "shock" of witnessing one’s blood sugar levels surge is not merely an emotional reaction but a crucial element of the learning process. Unlike less tangible biomarkers such as cortisol, glucose levels are highly responsive to immediate behavioral adjustments. "You see it, and you can change your behavior," he stated. "Next time, you make a different choice." He drew a compelling analogy to learning to drive: a speedometer provides essential feedback, enabling drivers to understand how their actions translate into tangible outcomes, much like a CGM allows individuals to connect their dietary and lifestyle choices with their physiological responses.
Beyond Hardware: AI-Powered Predictive Glucose Monitoring
While the efficacy of hardware-based CGMs is undeniable, the challenge of scalability for broader public health initiatives remains. Noosheen Hashemi, founder and CEO of January AI, addressed this by advocating for AI-driven solutions that can predict glucose responses without the necessity of a physical sensor. January AI’s proprietary technology utilizes machine learning models, trained on extensive CGM datasets, to forecast glucose fluctuations based on a range of user-inputted data points, including age, weight, activity levels, sleep patterns, and dietary intake.
"Our claim to fame is creating the world’s first continuous glucose monitor with AI," Hashemi stated, underscoring the innovative approach of leveraging predictive analytics. This method aims to provide actionable insights to hundreds of millions of individuals who may be undiagnosed with prediabetes or metabolic dysfunction, conditions often linked to poor glucose regulation.
The Sustained Challenge: Bridging the Gap Between Insight and Lasting Change
Despite the technological advancements, the panel acknowledged a significant hurdle: ensuring that the insights generated by these devices lead to sustained behavioral modifications. Sherry Frey, VP of Total Wellness at NielsenIQ, presented research indicating a common pattern of behavioral reversion. "We actually see about nine months in that a lot of behavior reverted," Frey noted. This phenomenon is often attributed to a decline in user engagement and a sense of fatigue associated with the continuous effort required to maintain new dietary habits.
This "drop-off" phenomenon highlights the critical need for health technologies to offer more than just raw data. The challenge lies in providing context, interpretation, and ongoing motivation to foster long-term adherence. Frey also pointed to a significant trend: the expanding demographic of wearable and health-tracking technology users. Contrary to initial assumptions that these devices are exclusive to affluent early adopters, NielsenIQ data reveals that one of the fastest-growing user segments includes individuals receiving SNAP benefits. These consumers are increasingly utilizing these tools for chronic disease management rather than solely for fitness optimization, indicating a broader and more urgent need for accessible metabolic health solutions. "The addressable market is much larger than people with diabetes," Frey emphasized.
Actionable Insights as the Key to Behavioral Persistence
The discussion then shifted to what truly drives lasting behavioral change. Peter Bodenheimer, U.S. venture partner at PeakBridge VC, drew a parallel to the impact of the Nest thermostat, suggesting that providing consumers with data—specifically, insights that clearly delineate the consequences of their actions—is paramount. "Insights that tell you, ‘if I do this, then something good or bad happens,’ tend to be the things that people respond to and maintain," Bodenheimer explained. This principle of clear cause-and-effect feedback is crucial for empowering individuals to make informed decisions and stick with them.
Navigating the Pitfalls: Misinformation and the Need for Context
The proliferation of health data also introduces potential challenges, including confusion, anxiety, and the spread of misinformation. Hashemi cited an instance where a user misinterpreted their glucose readings, believing their blood sugar should never exceed 110 mg/dL, a misconception likely amplified by unsubstantiated claims circulating on social media. "Metabolic fitness is how you go from fasted to fed efficiently," she clarified. "It’s a preposterous idea to keep your blood sugar the same all the time. So yes, there’s a lot of misinformation."
Dr. Zisser reiterated the importance of individual context in interpreting glucose data. The significance of a particular blood sugar spike can vary dramatically depending on an individual’s physiology, health goals, and lifestyle. A professional athlete, a person managing diabetes, or an individual aiming for weight loss will all interpret and respond to similar glucose readings differently.
The Horizon of Biosensing: Beyond Glucose
The conversation also ventured into other emerging biosensing technologies that promise to provide an even more holistic view of internal physiological states. Hashemi highlighted the development of implantable sensors capable of continuously monitoring multiple analytes for extended periods. Research is actively underway to measure substances like lactate, ketones, alcohol, and eventually insulin in real-time. "Yeah, there’s definitely implantables," Hashemi confirmed. "There’s one that reads 20 different analytes, including glucose. It lives, you have to inject it under your skin. It can live 900 days. And it’s still in animals. It’s not in humans yet. But these things are coming."
Privacy, Trust, and the Empowerment of Self-Care
As the scope of measurable biological signals expands, so do legitimate concerns regarding data privacy, trust, and ownership. Frey noted that while a significant portion of consumers desire a unified platform for their health data, a substantial number remain apprehensive about embedded sensors, fearing potential misuse of their information by insurers, governments, or corporations.
However, a counter-argument emerged, suggesting that the tangible benefits derived from these technologies could ultimately outweigh abstract privacy fears. When individuals experience demonstrable improvements in sleep quality, energy levels, or cognitive focus, a sense of trust in the technology can naturally develop. "No government, no doctor can make somebody healthy," Hashemi asserted. "The only person that can do that is yourself." This perspective places the onus and the ultimate power of health management squarely on the individual, with technology serving as a crucial enabler.
The Pursuit of Personalized Nutrition and the Future of Health Data Integration
The panel concluded by addressing the long-debated concept of personalized nutrition. While acknowledging that perfect precision may remain elusive, the consensus was that the convergence of biological data, artificial intelligence, and human context is steadily advancing the field towards more tailored dietary recommendations. "The gold lives in the combination of data," Hashemi stated, envisioning a future where consumer-generated health data seamlessly integrates with clinical care, particularly within the expanding landscape of value-based healthcare models.
Ultimately, the profound promise of next-generation health technology may lie less in predicting perfect outcomes and more in empowering individuals to take control of their well-being. Dr. Zisser offered a compelling pedagogical approach: introducing these feedback mechanisms to young students during their formative years, much like teaching them to drive with a speedometer. "When my dad taught me how to drive, he didn’t put me in a car without a speedometer, right? It’s like, have feedback, I have information. And so to give people that access to that, and not that they would need it all the time, but so they can learn how their choices impacts their glucose," he suggested.
The author echoed this sentiment, reflecting on the potential impact on long-term health outcomes had similar insights into the effects of specific foods on blood sugar been available during younger years. The integration of advanced biosensing and intelligent interpretation tools holds the potential to foster a generation more attuned to their bodies’ signals, paving the way for a healthier future.
To hear the full conversation with the experts, the audio recording of the CES 2026 session "From Brainwaves to Blood Sugar: How Next-Gen Tech Shapes Diets" is available [Link to recording, if applicable].
